DrugPatentWatch Archives
Click here to return to the current data set
|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Search for Tradename: ABILIFY
Summary for Tradename: ABILIFY
|
|
Latest news for ABILIFYThe Paradox of Choice: When More Medications Mean Less Treatment22 May 2013, 10:36 am Bristol-Myers Squibb's Management Presents at UBS Global Healthcare Services Conference (Transcript)21 May 2013, 3:13 pm The Top 3 Diseases Caused by Stress21 May 2013, 2:29 pm Otsuka Pharmaceutical and Lundbeck: Study Shows Effects of Treatment with ABILIFY MAINTENA™ (Aripiprazole) on ...21 May 2013, 10:00 am Adult drugs linked to deaths in kids13 May 2013, 9:22 am Why Psychiatry's Seismic Shift Will Happen Slowly8 May 2013, 9:47 am Drugs.com Releases Q1 Sales for Top 100 U.S. Drugs: Rough U.S Flu Season Boosts Numbers for Tamiflu6 May 2013, 8:59 am Judge OKs Claims Of Strict Liability Against Drugmaker3 May 2013, 2:23 pm Edimer Appoints William Aliski and Wendy L. Dixon, Ph.D. to Board of Directors2 May 2013, 8:15 am Courtesy of Yahoo News | ||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Exclusivity Expiration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Otsuka | ABILIFY | aripiprazole | INJECTABLE; INTRAMUSCULAR | 021866 | Sep 20, 2006 | RX | Yes | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Otsuka | ABILIFY | aripiprazole | INJECTABLE; INTRAMUSCULAR | 021866 | Sep 20, 2006 | RX | Yes | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Otsuka | ABILIFY | aripiprazole | INJECTABLE; INTRAMUSCULAR | 021866 | Sep 20, 2006 | RX | Yes | 5,006,528 | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Paragraph IV activity for: ABILIFY
| Drugname | Dosage | Strength | RLD | Submissiondate |
| aripiprazole | Oral Solution | 1 mg/mL | Abilify | 12/20/2007 |
| aripiprazole | Orally Disintegrating Tablets | 10 mg, 15 mg, 20 mg and 30 mg | Abilify | 11/15/2006 |
| aripiprazole | Tablets | 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg | Abilify | 11/15/2006 |
« Back to Dashboard
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc